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Methods as Sources of
DNA for Sequencing
BioTechniques 25:818-822 (November 1998)
ABSTRACT
DNA products generated from a region
of the measles virus genome by three RNA
reverse transcription and amplification
methods were cloned and sequenced, and
the results were compared in order to evalu-
ate the methods’ relative fidelities. The
methods were: (i) reverse transcription fol-
lowed by a nested polymerase chain reac-
tion (RT-nPCR), (ii) a combined RT-PCR
using rTth polymerase and (iii) nucleic acid
sequence-based amplification (NASBA).
NASBA was followed by RT-PCR with rTth
polymerase or RT using AMV reverse tran-
scriptase to generate DNA products for
cloning. Products from all three sets of re-
actions were cloned into a vector, pT7Blue,
and 790 bp of cloned DNA were sequenced
and analyzed for base changes to determine
the error rates for  each amplification
method.  Sequence analysis of cloned RT-
nPCR products showed no errors, whereas
cloned rTth mediated RT-PCR products
possessed an error rate of 0.38% and
cloned NASBA products 0.38%. Products
generated by NASBA followed by RT-PCR
with rTth polymerase possessed an error
rate of 1.9%. The results indicated that
cloned DNA products generated by RT-
nPCRs possessed least errors and that for
NASBA, RT of reaction products before
cloning and sequencing was preferable to
using RT-PCR.
INTRODUCTION
To confirm amplification reaction
specificity and to characterize nucleic
acid products, reaction products are of-
ten sequenced. For example, sequenc-
ing individual amplification products
generated from RNA or DNA detection
methods enables the sequence variation
within a particular RNA or DNA sam-
ple to be determined, providing valu-
able information concerning the quasi-
species distribution within a given
infected clinical sample (8).
Since incorporation errors are often
generated by enzymes involved with
nucleic acid amplification (5,9,12), it is
also desirable that a number of prod-
ucts are sequenced to obtain a good
consensus sequence. To achieve this, it
is frequently the case that individual
amplification products are cloned into a
plasmid vector and stabilized in a host
bacteria.
We compared the relative fidelities
of three different RNA amplification
strategies used for producing DNA for
sequencing. The methods were (i) re-
verse transcription (RT) using Moloney
murine leukemia virus (M-MLV) re-
verse transcriptase followed by a nested
polymerase chain reaction (nPCR) us-
ing Taq DNA polymerase (10), (ii) a
combined RT-PCR mediated by rTth
polymerase (7) and (iii) nucleic acid se-
quence-based amplification (NASBA)
using avian myoblastosis virus (AMV)
reverse transcriptase and T7 RNA poly-
merase (3,4).
In the case of RT-PCR of RNA,
DNA products can be cloned direct-
ly, whereas with NASBA single-
stranded RNA products must first
be converted to double-stranded
DNA before cloning. Individual
clones of such transformed bacteria




RT was performed using M-MLV
Reverse Transcriptase (Life Technolo-
gies, Paisley, Scotland, UK). One hun-
dred nanograms of total RNA from
measles-infected Vero cells (1) were
added to 10 µL of RT reaction buffer
containing 50 mM Tris-HC1, pH 8.3,
75 mM KC1, 10 mM dithiothreitol
(DTT), 3 mM MgC12, 0.5 mM each
dNTP (Advanced Biotechnologies, Ep-
som, England, UK), 0.75 µM down-
stream primer MV2 (Oswell DNA Ser-
vices, Southampton, England, UK), 2
U RNase Inhibitor (Life Technologies)
and 200 U M-MLV Reverse Transcrip-
tase. The reaction mixture was then
overlaid with 40 µL of mineral oil and
incubated at 37°C for 2.5 h. Table 1
shows primer sequences and annealing
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Primer Position Sequencea
MV1 (PCR) 1198–1219 TTAGGGCAAGAGATGGTAAGG
(Upstream/Outer)
MV2 (PCR) 1610–1631 GTTCTTCCGAGATTCCTGCCA
(Downstream/Outer)
MV3 (PCR) 1248–1269 AGCATCTGAACTCGGTATCAC
(Upstream/Inner)
MV5 (PCR) 1348–1368 GTTCGGTTCATAGTAAAGA
(Downstream/Inner)
MV4 (PCR) 1480–1501 AGCTCTCGCATCACTTGCTCT
(Downstream/Inner)
AB20 (NASBA) 1200–1219 AGGGCAAGAGATGGTAAGGA
(Upstream)
AB22 (NASBA) 1358–1379 AATTCTAATACGACTCACTATAGGG
(Downstream) GATCACCGTGTAGAAATGACA
PCR primers MV1 and MV2 give a first-round product of 433 bp. PCR primers
MV3 and MV4 give a second-round product of 253 bp. NASBA primers AB20 and
AB22 give an RNA product of 179 bases. Bold type shows T7 promoter region of
primer (1,2).
aOrientations of sequences shown are 5′→3′.
Table 1. Positions and Sequences of PCR Primers, NASBA Primers, Target Sites and Sequence of
the Internal Probe AB10.
positions.
Two microliters of the above RT re-
action were added to 48 µL of a first-
round PCR containing 20 mM Tris-
HC1, pH 8.4, 50 mM KC1, 0.5% W-1
detergent, 1.5 mM MgCl2, 0.2 mM
each dNTP (Advanced Biotechnolo-
gies), 0.25 µM of each outer primer
(MV1 and 2 [Oswell DNA Services])
and 1.75 U Taq DNA Polymerase (Life
Technologies). The reaction mixture
was then overlaid with 60 µL of miner-
al oil and thermally cycled in a Model
PHC-3 Thermal Cycler (Techne, Cam-
bridge, England, UK). This involved an
initial denaturation step of 94°C for 2
min followed by 35 cycles of 94°C for
30 s (denaturation), 56°C for 1 min
(primer annealing) and 72°C for 30 s
(extension). This was followed by a fi-
nal extension at 72°C for 5 min.
One microliter of the first-round re-
action mixture was added to 24 µL of
second-round PCR buffer made up with
the same reagent concentrations but
with an inner, nested primer pair MV3
and MV4 in place of MV1 and MV2.
The reaction mixture was overlaid with
40 µL of mineral oil and amplified for
25 more cycles using the protocol de-
scribed previously (1). 
rTth Mediated RT-PCR
One hundred nanograms of total
RNA from measles infected Vero cells
(see previous description) were added
to 40 µL of rTth reaction mixture con-
taining 50 mM bicine, pH 8.2, 115 mM
potassium acetate, 8% glycerol, 2.5
mM manganese acetate, 3 mM each
dNTP (Advanced Biotechnologies),
0.45 µM each primer (MV3 and MV4)
and 5 U rTth (PE Applied Biosystems,
Warrington, England, UK). The reac-
tion mixture was overlaid with 60 µL of
mineral oil and incubated at 60°C for
30 min to allow for RT. This was fol-
lowed by denaturation at 94°C for 2
min and then 40 cycles of 94°C for 1
min (denaturation), 56°C for 1 min (an-
nealing/extension) and a final extension
at 60°C for 7 min (1,2).
NASBA
One hundred nanograms of total
RNA from measles-infected Vero cells
(see previous) were added to 10 µL of
NASBA buffer containing (per 20 µL
reaction) 40 mM Tris-HC1, pH 8.5, 12
mM MgC12, 70 mM KC1, 5 mM DTT,
1 mM each dNTP, 2 mM ATP, 2 mM
UTP, 2 mM CTP, 1.5 mM GTP, 0.5
mM ITP and 1 µM of each primer
(AB20 and AB22, Table 1). The mix-
ture was incubated at 65°C for 5 min
and then 41°C for 5 min. A 5-µL vol-
ume containing the following enzyme
mixture was subsequently added; 0.08
U RNase H, 32 U T7 RNA Polymerase
(both from Amersham Pharmacia
Biotech, Milton Keynes, England, UK)
and 6.5 U AMV Reverse Transcriptase
(Takara Biomedicals, Seigagaku,
Japan). The reaction mixture was cen-




Polymerase Polymerase NASBA Polymerase
Error rate 0% 0.38% 0.38% 1.9%
Base A → T A → T A → G (3)
Changes C → T G → C A → T
G → A G → T C → G
C → T
G → C
T → A (2)
T → C (4)
T → G (2)
Table 2. Error Rates and Base Changes Found for Each of the Three Amplification Methods
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trifuged briefly at 10 000× g and then
incubated at 41°C for 1.5 h (1).
Cloning of PCR Products
Measles PCR products were elec-
trophoresed in a 1% (wt/vol) low-melt-
ing-point agarose gel (BioGene Ltd,
Cambridge, England, UK). A gel slice
containing the PCR product was ex-
cised and DNA was extracted using the
Wizard PCR Preps DNA Purification
System (Promega, Southampton, Eng-
land, UK). Gel-purified PCR products
were cloned into the NsiI site of plas-
mid pT7Blue T-Vector (Novagen/AMS
Biotechnology, Witney, England, UK)
using T4 DNA Ligase (Life Technolo-
gies) according to the manufacturer’s
instructions.
Recombinant plasmids were trans-
formed into E. coli NovaBlue Compe-
tent Cells (Novagen/AMS Biotechnolo-
gy) and subsequently cultured according
to the manufacturer’s instructions.
Ten white clones from each transfor-
mation were checked for the presence
of insert DNA by digestion of plasmid
DNA, recovered using the Wizard
Miniprep Kit (Promega) with NsiI (in-
sert DNA contained a unique NsiI site).
Five micrograms of recombinant plas-
mid DNA were precipitated with 0.1
vol of 5M sodium acetate and 2 vol of
ice-cold ethanol. The pellet was washed
three times with 70% (vol/vol) aqueous
ethanol before resuspension in 10 µL of
sterile double-distilled water (ddH2O).
Cloning of NASBA Products
NASBA RNA products were con-
verted to cDNA by two methods before
cloning: (i) by RT-PCR using rTth and
(ii) by RT (without PCR) using a Copy
Kit (Invitrogen NV, Leek, The Neth-
erlands). In both cases, the NASBA re-
action mixture was treated with phenol/
chloroform to remove protein and RNA
precipitated by addition of 0.6 vol iso-
propanol before use in RT or RT-PCR.
The RNA was collected by centrifuga-
tion at 12000× g for 10 min and the pel-
let resuspended in sterile ddH2O.(i) One nanogram of purified NAS-
BA product was used in a rTth mediat-
ed RT-PCR as described previously but
with primers MV3 and MV5 (Table 1).
Product identity and size was evaluated
by agarose gel electrophoresis. Subse-
quently, the cDNA was gel-purified (see
previous description) and cloned as de-
scribed in Cloning of PCR Products.
(ii) Five micrograms of purified
NASBA product were used together
with the Copy Kit to prepare cDNA
according to the manufacturer’s in-
structions. Subsequently, the reaction
mixture was extracted with phenol/
chloroform, and DNA was precipitated
by addition of 0.1 vol of 3 M sodium
acetate (pH 5.0) and 2.5 vol of ice-cold
ethanol followed by incubation at 
-20°C for 16 h. After centrifugation at
12 000× g for 15 min at 4°C, the super-
natant was discarded, the DNA pellet
washed 2× in 70% (vol/vol) aqueous
ethanol and resuspended in 20 µL of
sterile ddH2O. The 5′ termini of the
blunt-ended cDNA were then phospho-
rylated by incubating 10 pmol of puri-
fied cDNA in a 50-µL reaction contain-
ing T4 Polynucleotide Kinase reaction
buffer, 4 mM ATP and 15 U T4 Poly-
nucleotide Kinase for 5 min at 37°C.
Subsequently, reactions were terminat-
ed by adding 2 µL of 0.5 M EDTA, pH
8.0. Reaction mixtures were treated
with phenol/chloroform, and phospho-
rylated products were precipitated and
cloned as described previously in the
Cloning RT-PCR Products section.
Sequencing
Sequencing was performed using a
Thermo Sequenase Cycle Sequenc-
ing Kit (Amersham Pharmacia Biotech,
Little Chalfont, Bucks, England, UK)
according to the manufacturer’s in-
structions. DNA from 10 clones gener-
ated by each method was prepared and
the 79-bp segment of each clone that
was located between primers MV3 and
MV5 was sequenced and analyzed for
base changes. A total of 790 bases for
each method were analyzed.
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RESULTS AND DISCUSSION
In a total of 790 bp of DNA se-
quenced for each amplification method
from cloned reaction products, the RT-
PCR method using Taq DNA poly-
merase was observed to have generated
no base changes, whereas both RT-PCR
using rTth polymerase and NASBA fol-
lowed by RT, generated 3 base changes
(error rate = 0.38% for both). However,
a total of 15 base changes (error rate =
1.9%) following NASBA and RT-PCR
using rTth polymerase were observed.
The difference in error rate observed for
NASBA products cloned following RT-
PCR and RT alone was found to be sta-
tistically significant (P = 0.009) using a
chi square test. Table 2 summarizes the
error rates and indicates specific errors
produced by the four methods.
These results show that RT-PCR us-
ing M-MLV reverse transcriptase and
Taq DNA polymerase generates fewer
errors than either RT-PCR using rTth
polymerase or NASBA. The observed
error rate of 0.38% for NASBA fol-
lowed by RT is significantly higher
than that reported by Sooknanan et al.
(0.03%) (11). Furthermore, unlike
Sooknan’s findings, no deletions or in-
sertions were observed in this study.
A possible explanation for the high
error rate observed in sequences of
DNA produced by NASBA followed
by rTth-mediated RT-PCR could be the
inclusion of inosine triphosphate (ITP)
in the NASBA reaction mixture. ITP is
included to improve the efficiency of
NASBA reactions and, as a result,
NASBA reaction products can possess
ITP. Because inosine can base pair with
all four bases (6), it is possible that
when NASBA products are used as
templates for rTth-mediated RT-PCR,
the enzyme might incorporate any base
when it reaches an inosine position in
the template sequence. These ‘base
changes’ are detected following clon-
ing and sequencing.
The large numbers of errors generat-
ed during NASBA followed by RT-
PCR with rTth polymerase indicates
that this approach to cloning and se-
quencing NASBA products should only
be used when large numbers of cloned
reaction products are available for
analysis to generate an accurate con-
sensus sequence. Although recombi-
nant plasmid vectors containing
NASBA products may be useful for
long-term storage and in vitro tran-
scription and translation studies, this
approach is not an ideal method for
generating error-free DNA for sequenc-
ing. Conversely, reverse transcription
of NASBA products to generate dou-
ble-stranded cDNA for direct cloning
without amplification leads to fewer er-
rors reported in their sequences. 
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